Commission Implementing Regulation (EU) 2022/20 of 7 January 2022 laying down rules for the application of Regulation (EU) No 536/2014 of the European Parliament and of the Council as regards setting up the rules and procedures for the cooperation of the Member States in safety assessment of clinical trials (Text with EEA relevance)
Article 12The role of the Clinical Trials Coordination and Advisory Group in coordinated safety assessment
In force · version of Jan 30, 2022
1.The national contact points designated in accordance with Article 83 of Regulation (EU) No 536/2014 shall communicate, within theClinical Trials Coordination and Advisory Group, any concerns related to the functioning of the coordinated safety assessments that they receive from their designating Member States, the safety assessing Member States, or the public.
2.The Clinical Trials Coordination and Advisory Group shall investigate and address concerns related to the functioning of the coordinated safety assessment in due time.